Protara Therapeutics Inc (NASDAQ: TARA) — Healthcare · Share Price, Chart & Market Data
About: Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.13 (-2.47%)
TARAProtara Therapeutics Inc
Loading watchlist status…
Trade TARA now
Protara Therapeutics Inc share price
TARA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
25 Apr, 3:09 pm GMT+0
TARA price performance
-3.208%
5D
2.395%
1M
-4.647%
YTD
24.818%
1Y
TARA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
25 Apr, 3:09 pm GMT+0
TARA details
TARA Market Signals